Exclusive Supply Agreement: A contractual arrangement where UFP Technologies ( UFPT 2.21%) is the sole supplier of specified ...

Q4 2025 guidance -- Projected total revenue of $371 million to $377 million; subscription revenue of $258 million to $261 ...

Total Revenue -- $21.2 million for the third quarter of 2025, up 16%, driven by MRI compatible IV infusion pump and ...

Acquisition Announcement -- VSE Corporation ( VSEC 0.75%) signed a definitive agreement to acquire Aero 3 for $350 million in ...

Upcoming product launches -- AMP-007 inhalation on track for mid-2026 launch targeting a $1.5 billion market; generic ...

Disposition Activity -- Q3 proceeds totaled $19.3 million, with $4.6 million in gains; year-to-date sales reached $133.8 ...

Recognition -- The company achieved a ranking of 74th in Time Magazine's America's Growth Leaders 2026 list, among over 4,000 ...

gTLD process -- The ICANN 2026 round of new generic Top-Level Domains is intended to start in Q2 2026, with no future ...

Join us as we dissect Lululemon's stock performance and explore whether it can reclaim its former glory in the competitive ...

Quantum Computing Investors Need to Wake Up! IonQ's $2.5 Billion Warning Can't Be Ignored Any Longer. So far, these ...

One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.

Earlier this year, Bill Ackman's fund took a large stake in a company that it views as a free cash flow machine with ...